The document outlines a request for the procurement of two ClearSight upgrade kits for the Hemosphere system at David Grant Medical Center. Due to the proprietary technology of these kits, only Edwards Life Sciences and 1st American Medical Distributors, Inc. can supply and install the required equipment. A sources sought notice was issued on SAM.gov, confirming interest from both vendors, aligning with past contract actions where these two suppliers were consistently chosen for similar requirements. The document highlights that the single-source procurement is justified under FAR 13.106-1(b)(1), indicating no alternative vendors can meet the needs due to the specialized nature of the upgrades. The contracting officer, Maekyla Jane S. Rosendo, GS-12, states the necessity of this approach until the equipment at the facility is replaced, reinforcing the challenges in fostering competition for this specific technology. This procurement process emphasizes the restrictions due to proprietary technology, which limits alternatives in sourcing necessary medical upgrades.
The document outlines a government procurement action to obtain two proprietary ClearSight upgrade kits for the Hemosphere system at the David Grant Medical Center, which can only be provided by Edwards Lifesciences or their authorized distributor, 1st American Medical Distributors. The need for these upgrades arises from the unique compatibility of the equipment, confirmed through communications from sales representatives. Efforts to solicit competitive bids revealed no alternatives, as prior market research indicated that similar contracts had consistently been awarded to the same vendors. The contracting officer determined that only a single source was available under FAR guidelines, noting that the proprietary nature of the equipment limits future competition until a potential equipment overhaul occurs. This summary reflects the government’s position on acquiring essential medical technology while adhering to procurement regulations.
The 60th Contracting Squadron at Travis Air Force Base has issued a Request for Quotation (RFQ), FA442724Q0177, for the HemoSphere Clearsight Upgrade. The contract aims to provide scale calibrations specific to the 60th Aerial Port Squadron, with proposals due by 23 September 2024. The contract will be a Firm Fixed Price agreement, utilizing simplified procedures in accordance with federal regulations. Vendors must provide HemoSphere Clearsight Upgrade Kits and a Pressure Controller Cover as per the Statement of Need, with delivery to Travis AFB.
Offerors must submit complete quotes including adherence to the terms and conditions, financial capability confirmations, and detailed product specifications to evaluate technical capabilities. Additionally, a completed Offeror Representations and Certifications form is necessary, and vendors must be registered in the System for Award Management (SAM). The evaluation will consider price and the technical capability of products offered. Specific clauses and provisions concerning telecommunications equipment and compliance with various federal standards are included, reflecting the regulatory framework guiding this acquisition.
The 60th Contracting Squadron at Travis Air Force Base issued a Request for Quotation (RFQ) for a Firm Fixed Price contract for the Hemosphere Clearsight Upgrade Kit, with solicitation number FA442724Q0177. The RFQ was posted on September 18, 2024, and responses are due by September 23, 2024, at 8:00 AM PST. This solicitation is open to all bidders under Full and Open Competition, classified under NAICS code 339112.
Offerors are required to provide a detailed quote including company information, technical specifications, and financial documentation demonstrating resource capability. Evaluation criteria focus on price and technical capability that meets government needs. The government reserves the right to award without further negotiation.
The document emphasizes compliance with various Federal Acquisition Regulation (FAR) clauses and mandates registration in the System for Award Management (SAM). Key considerations include prohibitions on contracting for covered telecommunications equipment and maintaining standards for ethical practices and legal compliance. The acquisition supports the Air Force's operational capabilities by allowing for upgrades to critical equipment.
The David Grant Medical Center at Travis AFB seeks to procure two HemoSphere ClearSight systems for non-invasive hemodynamic monitoring. This upgrade is necessary to replace four outdated EV1000 units which have reached their end of life, enhancing the existing ICU's capabilities. The HemoSphere ClearSight systems will provide critical measurements, including stroke volume and cardiac output, aiding in the evaluation of hemodynamic status and treatment guidance.
The vendor is required to deliver two HemoSphere ClearSight Upgrade Kits, along with compatible software and training for Critical Care Flight personnel. Payment terms stipulate invoicing only after equipment delivery and completion of training. The contractor must ensure delivery within 30 days of award and maintain communication with designated personnel. Additionally, training must be conducted by a certified OEM trainer to ensure effective operation of the new equipment. This initiative reflects the military's commitment to enhancing healthcare delivery for its personnel.